keine Finanzberatung
🔍 Search…
📊 Portfolio ← All

TECH · Bio-Techne

S&P 500 #488 · Nasdaq

Risiko 5/10 · Biotools Recovery · $72.07 ▲ 0.63%

Kennzahlen

  • Price $72.07
  • Market cap $11.2B
  • P/E (ttm) 102.96
  • Div yield 0.45%
  • 52-wk range $43.20 – $72.16
  • Index rank #488 / —

Wichtigste Risiken

  • Elevated P/E (102x) requires flawless execution (Valuation) — HIGH
  • Life sciences research spending cuts (NIH funding risk) (Revenue) — HIGH
  • Biopharma customer budget cycles (Demand) — MED
  • Protein and cell biology tools competition (Market share) — LOW

Fazit

Life sciences tools company (cytokines, proteins, cell biology reagents); trading near 52-week high but commanding a very high 102x P/E.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.